Biography
Biography
Advancing Biology to Belief
Advancing
Biology to Belief
We shape commercial, medical and market access strategies to unlock value—faster, sharper and leaner—through automated intelligence with expert judgment.
We shape commercial, medical and market access strategies to unlock value—faster, sharper and leaner—through automated intelligence with expert judgment.
Next-Generation Oral GLP-1 Receptor Agonist
Product
Biography is a deep bio strategic consulting firm. We deploy AutoBio—our proprietary AI platform—trained on 50M+ authoritative life sciences data sources, and predictive patient models to shape pipeline, product, and portfolio strategies and optimize full value across the therapeutic lifecycle.
Five domains. One operating layer.
Product
Portfolio
Medical
Access
Launch
From First Data to Market Belief
Product
Defining asset strategy, commercial positioning, and go-to-market approach across the full product lifecycle
Portfolio
Optimizing asset prioritization, therapeutic area strategy, and BD decisions across the portfolio
Medical
Building the evidence strategy, publication roadmap, medical communications and KOL engagement plan that shapes clinical belief
Access
Optimizing pricing, payer strategy, and value demonstration to establish coverage and formulary positioning at launch
Launch
Integrating commercial, medical, and access strategy into a single coordinated go-to-market plan
Biography strategists combine PhD and MD-level scientific rigor with 50+ drug launches across the most competitive therapeutic categories —deploying AutoBio to deliver the strategic intelligence and speed your science demands. Traditional consulting firms can't move at this speed. Legacy models can't match this depth. Biography does both.
Biography strategists combine PhD and MD-level scientific rigor with 50+ drug launches across the most competitive therapeutic categories— deploying AutoBio to deliver the strategic intelligence and speed your science demands. Traditional consulting firms can't move at this speed. Legacy agencies can't match this depth. Biography does both.
AutoBio is Biography's proprietary AI platform—purpose-built for deep bio by unifying science, signal and strategy into a single operating layer. Built on 25+ years of biopharma launch expertise, powered by 50M+ authoritative life sciences data sources, and predictive patient models encoded into apps and workflows, AutoBio delivers in days what legacy models take months to produce.
AutoBio is Biography's proprietary AI platform— purpose-built for deep bio strategy by unifying science, signal and strategy into a single operating layer. Built on 25+ years of pharmaceutical launch expertise, powered by 300M+ claims and EMR, 50M+ authoritative life sciences data sources, and predictive patient models encoded into apps and workflows, AutoBio delivers in days what legacy models take months to produce.
How We Work
01
Strategic Intelligence in Days, Not Weeks
Commercial positioning, market access strategy, pipeline assessment, and medical affairs planning delivered in 5–7 days. AutoBio automates the intelligence work—we deliver answers faster than any traditional firm can move.
02
Complete Source Transparency
Every strategic recommendation traces to an authoritative source—FDA filings, clinical registries, peer-reviewed literature, or proprietary patient data. Not assumptions. Not generic AI outputs. Audit-ready by default.
03
40% AI Automated.
100% Expert-Led.
AutoBio handles the intelligence. Biography strategists handle the judgment. Faster decisions, sharper strategy, without sacrificing rigor.
04
Built for Biopharma.
Not Adapted for It.
Powered by 50M+ authoritative life sciences data sources, and driven by predictive patient models—purpose-built for biopharma. Not general-purpose AI adapted for it.
How We Work
01
Strategic Intelligence in Days, Not Weeks
Commercial positioning, market access strategy, pipeline assessment, and medical affairs planning delivered in 5–7 days. AutoBio automates the intelligence work—we deliver answers faster than any traditional firm can move.
02
Complete Source Transparency
Every strategic recommendation traces to an authoritative source—FDA filings, clinical registries, peer-reviewed literature, or proprietary patient data. Not assumptions. Not generic AI outputs. Audit-ready by default.
03
40% AI Automated. 100% Expert-Led.
AutoBio handles the intelligence. Biography strategists handle the judgment. Faster decisions, sharper strategy, without sacrificing rigor.
04
Built for Biopharma. Not Adapted for It.
Powered by 50M+ authoritative life sciences data sources, and driven by predictive patient models—purpose-built for biopharma. Not general-purpose AI adapted for it.
How We Work
01
Strategic Intelligence in Days, Not Weeks
Commercial positioning, market access strategy, pipeline assessment, and medical affairs planning delivered in 5–7 days. AutoBio automates the intelligence work—we deliver answers faster than any traditional firm can move.
02
40% AI Automated. 100% Expert-Led.
AutoBio handles the intelligence. Biography strategists handle the judgment. Faster decisions, sharper strategy, without sacrificing rigor.
03
Complete Source Transparency
Every strategic recommendation traces to an authoritative source—FDA filings, clinical registries, peer-reviewed literature, or proprietary patient data. Not assumptions. Not generic AI outputs. Audit-ready by default.
04
Built for Biopharma. Not Adapted for It.
Powered by 50M+ authoritative life sciences data sources, and driven by predictive patient models—purpose-built for biopharma. Not general-purpose AI adapted for it.
+
+
Deep Bio-Coded Workflows
Platform
01
01
BioFlow™
BioFlow™
Strategic Workflows
02
02
BioPilot™
BioPilot™
Conversational intelligence
03
03
BioSignal™
BioSignal™
Competitive Intelligence
%
%
Strategy Consulting Work, Automated
Large Biopharma
"Biography delivered our Phase 3 commercialization strategy in 5 days. That work traditionally takes 6–8 weeks. We moved our launch timeline up without compromising the strategic rigor we needed."
Series A Biotech
"Biography made institutional-grade commercialization strategy accessible at Series A. Competitive positioning and investor frameworks in days, not months. Early-stage timelines don't accommodate 12-week consulting cycles—Biography gets that."
Midsize Biopharma
"AutoBio surfaces competitive intelligence we couldn't get anywhere else before board meetings and key data readouts. But it's the experts layered on top that make it actionable strategy. That combination is unlike anything else in the market."
Oncology Biotech
"The combination of AI intelligence and expert strategy is the differentiator. AutoBio gets you to insight fast—Biography's strategists make sure it's the right insight. We get strategic depth in days that would normally take weeks, without any quality trade-off."
Oncology Biotech
"The scientific rigor is what sets them apart. They understand mechanism subtleties, competitive context, and regulatory realities at a level most strategy consultants don't. The depth is there when it matters."
Specialty Pharma
"Having strategists who understand both the science and the commercial imperatives changed everything. They don't need to be educated on the biology—they start from insight and move fast."
Insights
Work With Us
Advance biology to belief—
sharper, faster, and leaner.
Connect with our Biography team to start a conversation.
Work With Us
Advance biology to belief—
sharper, faster, and leaner.
Connect with our Biography team to start a conversation.
Work With Us
Advance biology to belief—sharper, faster, and leaner.
Connect with our Biography team to start a conversation.